PATASHNIK, SHULAMIT,LICHT, DANIELLA,GILBERT, ADRIAN
申请号：
NZ57384607
公开号：
NZ573846A
申请日:
2007.06.12
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed is a pharmaceutical composition comprising a pharmaceutically acceptable salt of N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-l-methyl-2-oxoquinoline-3-carboxamide, N-methylglucamine, and a pharmaceutically acceptable carrier for treating, or alleviating a symptom of, a form of multiple sclerosis.
